Rankings
▼
Calendar
INGN FY 2023 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena
INGN
Inogen, Inc.
$171M
FY 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$316M
-16.3% YoY
Gross Profit
$127M
40.1% margin
Operating Income
-$109M
-34.7% margin
Net Income
-$102M
-32.5% margin
EPS (Diluted)
$-4.42
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$30M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$326M
Total Liabilities
$121M
Stockholders' Equity
$205M
Cash & Equivalents
$125M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$316M
$377M
-16.3%
Gross Profit
$127M
$154M
-17.5%
Operating Income
-$109M
-$85M
-28.3%
Net Income
-$102M
-$84M
-22.3%
← Q4 2022
All Quarters
Q1 2023 →